<html><body><h2>Case: 1034666</h2><h3> CDS Time: 2011-05-31</h3>
<patient name=1034666>
62.0 year old White_Non-Hispanic Female
<p><b>Lab & Note Entry Values:</b> <table>
<b><tr><td width="200">Lab</td><td width="200">Value</td><td width="200">Date</td></tr></b>
<tr><td width="200">Age</td><td width="200">62</td><td width="200">1970-1-1</td></tr>
<tr><td width="200">UrineProtein_12h</td><td width="200">151</td><td width="200">1962-7-15</td></tr>
<tr><td width="200">Calcium</td><td width="200">11</td><td width="200">1962-7-13</td></tr>
<tr><td width="200">UrineProtein_24h</td><td width="200">151</td><td width="200">1962-7-15</td></tr>
<tr><td width="200">Alkaline_phosphatase</td><td width="200">314</td><td width="200">1962-5-19</td></tr>
<tr><td width="200">Glucose</td><td width="200">97</td><td width="200">1958-5-3</td></tr>
<tr><td width="200">Phosphorus</td><td width="200">4</td><td width="200">1962-7-13</td></tr>
<tr><td width="200">LDL_Cholesterol</td><td width="200">114</td><td width="200">1962-7-13</td></tr>
<tr><td width="200">Chloride</td><td width="200">103.0</td><td width="200">1962-7-13</td></tr>
<tr><td width="200">HDL_Cholesterol</td><td width="200">40</td><td width="200">1962-7-13</td></tr>
<tr><td width="200">Diastolic_BP</td><td width="200">80</td><td width="200">1962-9-6</td></tr>
<tr><td width="200">BNP</td><td width="200">624</td><td width="200">1962-2-12</td></tr>
<tr><td width="200">Weight</td><td width="200">220</td><td width="200">1962-9-6</td></tr>
<tr><td width="200">Uric_Acid</td><td width="200">13</td><td width="200">1962-1-2</td></tr>
<tr><td width="200">HbA1C</td><td width="200">6</td><td width="200">1962-5-18</td></tr>
<tr><td width="200">Triglycerides</td><td width="200">266</td><td width="200">1962-7-13</td></tr>
<tr><td width="200">Total_Cholesterol</td><td width="200">204</td><td width="200">1962-7-13</td></tr>
<tr><td width="200">SGOT</td><td width="200">120</td><td width="200">1962-5-19</td></tr>
<tr><td width="200">Systolic_BP</td><td width="200">130</td><td width="200">1962-9-6</td></tr>
<tr><td width="200">Total_Bilirubin</td><td width="200">0</td><td width="200">1962-5-19</td></tr>
<tr><td width="200">Height</td><td width="200">64</td><td width="200">1962-9-6</td></tr>
<tr><td width="200">Potassium</td><td width="200">4</td><td width="200">1962-7-13</td></tr>
<tr><td width="200">Cholesterol</td><td width="200">204</td><td width="200">1962-7-13</td></tr>
<tr><td width="200">BUN</td><td width="200">37</td><td width="200">1962-7-13</td></tr>
<tr><td width="200">HCT</td><td width="200">31</td><td width="200">1962-7-13</td></tr>
<tr><td width="200">HGB</td><td width="200">10</td><td width="200">1962-7-13</td></tr>
<tr><td width="200">Sodium</td><td width="200">136</td><td width="200">1962-7-13</td></tr>
<tr><td width="200">Albumen</td><td width="200">3</td><td width="200">1962-7-13</td></tr>
<tr><td width="200">Creatinine</td><td width="200">1.6</td><td width="200">1962-7-13</td></tr>
<tr><td width="200">Glycosylated_Hemoglobin</td><td width="200">6</td><td width="200">1962-5-18</td></tr>
<tr><td width="200">UrineProtein_Qualitative</td><td width="200">151.0</td><td width="200">1962-7-15</td></tr>
<tr><td width="200">UrineProtein_Spot</td><td width="200">151</td><td width="200">1962-7-15</td></tr>
<tr><td width="200">Pulse</td><td width="200">76</td><td width="200">1962-9-6</td></tr>
<tr><td width="200">PLT</td><td width="200">268</td><td width="200">1962-7-13</td></tr>
<tr><td width="200">WBC</td><td width="200">12</td><td width="200">1962-7-13</td></tr>
<tr><td width="200">eGFR</td><td width="200">35</td><td width="200">1962-7-13</td></tr>
<tr><td width="200">target_HBA1c</td><td width="200">7.0</td><td width="200">1962-8-2</td></tr>
<tr><td width="200">SGPT</td><td width="200">73</td><td width="200">1962-5-19</td></tr>
<tr><td width="200">Pacemaker</td><td width="200"></td><td width="200">1962-2-15</td></tr>
<tr><td width="200">Renal_Insufficiency</td><td width="200"></td><td width="200">1962-3-19</td></tr>
<tr><td width="200">Renal disease</td><td width="200"></td><td width="200">1962-3-19</td></tr>
<tr><td width="200">Heart_Failure</td><td width="200"></td><td width="200">1962-9-6</td></tr>
<tr><td width="200">Hypercalcemia</td><td width="200"></td><td width="200">1962-7-21</td></tr>
<tr><td width="200">Hyperlipidemia</td><td width="200"></td><td width="200">1962-1-7</td></tr>
<tr><td width="200">Hypertension</td><td width="200"></td><td width="200">1962-6-3</td></tr>
<tr><td width="200">Occulusion of cerebral arteries</td><td width="200"></td><td width="200">1961-8-6</td></tr>
<tr><td width="200">Cardiomyopathy</td><td width="200"></td><td width="200">1962-8-30</td></tr>
<tr><td width="200">Disorders Lipid Metabolism</td><td width="200"></td><td width="200">1962-1-7</td></tr>
<tr><td width="200">CKD</td><td width="200"></td><td width="200">1962-2-16</td></tr>
<tr><td width="200">DM-Type2</td><td width="200"></td><td width="200">1962-8-2</td></tr>
<tr><td width="200">B 12</td><td width="200">>1000</td><td width="200">1962-2-23</td></tr>
<tr><td width="200">Race</td><td width="200">White_Non-Hispanic</td><td width="200"></td></tr>
<tr><td width="200">Sex</td><td width="200">Female</td><td width="200"></td></tr>
</table>
<p><b>Medications:</b> aspirin(81.0) labetalol(5.0) atorvastatin(20.0) nitrate(30.0) hydralazine(2.5) digoxin(0.25) carvedilol(25.0) furosemide(0.0) Insulin(0.04) enalapril(20.0) glipizide(10.0) 
<p><b>Problems:</b> <table>
<tr><td width="200"><b>Problem Class</b></td><td width="200"><b>First/Last Dates Reported</b></td><td width="200"></td></tr>
<tr><td width="200">CRI</td>
<td width="200"></td>
<td width="200"> Renal Insufficiency[Creatinine(1.6/1962-7-13) && Sex(Female) && Creatinine(1.6/1962-7-13)]()</td></tr>
<tr><td width="200">Laboratory_Test_Result_Syndrome</td>
<td width="200"></td>
<td width="200"> Hyperuricemia[Uric_Acid(12.8/1962-1-2)]()</td></tr>
<tr><td width="200">Target_Organ_Damage_Clinical_Cardiovascular_Disease</td>
<td width="200"></td>
<td width="200"> TOD/CCD[presence of heart failure]()</td></tr>
<tr><td width="200">Dyslipidemia Lab criteria</td>
<td width="200"></td>
<td width="200"> Dyslipidemia Lab criteria[Total_Cholesterol(204.0/1962-7-13)]()</td></tr>
<tr><td width="200">Heart Failure and BP not controlled</td>
<td width="200"></td>
<td width="200"> Heart Failure[presence of heart failure && BP not adequately controlled based on most recent BPTreatment_Diastolic_BP(80/null)]()</td></tr>
<tr><td width="200">Diabetes WITHOUT proteinuria/renal manifestations</td>
<td width="200"></td>
<td width="200"> Diabetes[presence of diabetes mellitus && Absence of diabetic with renal manifestations && Absence of diabetic nephropathy && Absence of diabetic nephrosis && Proteinuria equals trace or above && Absence of ARB]()</td></tr>
<tr><td width="200">DM and BP not controlled</td>
<td width="200"></td>
<td width="200"> Diabetes[presence of DM && BP not adequately controlled based on most recent BPTreatment_Diastolic_BP(80/null)]()</td></tr>
<tr><td width="200">DM BP not controlled  >=1 drug</td>
<td width="200"></td>
<td width="200"> Diabetes[BP not adequately controlled based on most recent BPTreatment_Diastolic_BP(80/null) && presence of diabetes mellitus && Antihypertensive_Agents]()</td></tr>
<tr><td width="200">Major Cardiovascular Risk Factor</td>
<td width="200"></td>
<td width="200"> Major Cardiovascular Risk Factor[Sex(Female) && Age(62.0/1970-1-1)]()</td></tr>
<tr><td width="200">Dyslipidemia Lab or ICD9</td>
<td width="200"></td>
<td width="200"> Dyslipidemia Lab or ICD9[presence of dyslipidemia lab criteria]()</td></tr>
<tr><td width="200">CKD by eGFR</td>
<td width="200"></td>
<td width="200"> CKD by eGFR[eGFR(35.0/1962-7-13)]()</td></tr>
<tr><td width="200">CKD by eGFR or ICD9 codes</td>
<td width="200"></td>
<td width="200"> CKD[eGFR(35.0/1962-7-13)]()</td></tr>
<tr><td width="200">On meds & Presence of strong contraindication to HCTZ or using bad drug partner</td>
<td width="200"></td>
<td width="200"> Hypertension[taking furosemide && Antihypertensive_Agents]()</td></tr>
<tr><td width="200">active prescription for furosemide</td>
<td width="200"></td>
<td width="200"> active prescription for furosemide[taking furosemide]()</td></tr>
<tr><td width="200">on >= 1 med</td>
<td width="200"></td>
<td width="200"> Combination therapy for HTN[Antihypertensive_Agents]()</td></tr>
<tr><td width="200">taking >= 2 anti hypertensive meds</td>
<td width="200"></td>
<td width="200"> Combination therapy for HTN[Antihypertensive_Agents]()</td></tr>
<tr><td width="200">On 1 drug and there exists contraindicated drug or a compelling drug not given</td>
<td width="200"></td>
<td width="200"> On 1 drug and there exists contraindicated drug or a compelling drug not given[there exists a compellingly indicated drug that is not already given]()</td></tr>
<tr><td width="200">drug intolerance ACE/ARB OR hypotension OR renal insufficiency</td>
<td width="200"></td>
<td width="200"> drug intolerance ACE/ARB OR hypotension OR renal insufficiency[presence of renal insufficiency ICD9]()</td></tr>
<tr><td width="200">Absence of Stage D HF</td>
<td width="200"></td>
<td width="200"> Absence of Stage D HF[Not Stage D HF (refractory end stage HF)Stage D HF (refractory end stage HF)]()</td></tr>
<tr><td width="200">Renal-Urinary_Diseases</td>
<td width="200">1962-02-16</td>
<td width="200"> CKD()</td></tr>
<tr> <td width="200"></td>
<td width="200">1962-03-19</td>
<td width="200"> Renal_Insufficiency()</td></tr>
<tr> <td width="200"></td>
<td width="200">1962-03-19</td>
<td width="200"> Renal disease()</td></tr>
<tr><td width="200">Hepatobiliary_Diseases</td>
<td width="200"></td>
<td width="200"> Active Liver Disease[SGOT(120.0/1962-5-19)]()</td></tr>
<tr><td width="200">CCS-7.4</td>
<td width="200">1961-08-06</td>
<td width="200"> Occulusion of cerebral arteries()</td></tr>
<tr><td width="200">CCS-7.2</td>
<td width="200">1962-09-06</td>
<td width="200"> Heart_Failure()</td></tr>
<tr> <td width="200"></td>
<td width="200">1962-08-30</td>
<td width="200"> Cardiomyopathy()</td></tr>
<tr><td width="200">Hypertension_Inclusive</td>
<td width="200">1962-06-03</td>
<td width="200"> Hypertension()</td></tr>
<tr><td width="200">Pacemaker</td>
<td width="200">1962-02-15</td>
<td width="200"> Pacemaker()</td></tr>
<tr><td width="200">Metabolic&Nutritional_Diseases</td>
<td width="200">1962-01-07</td>
<td width="200"> Disorders Lipid Metabolism()</td></tr>
<tr> <td width="200"></td>
<td width="200">1962-07-21</td>
<td width="200"> Hypercalcemia()</td></tr>
<tr><td width="200">Endocrine_Diseases</td>
<td width="200">1962-08-02</td>
<td width="200"> DM-Type2()</td></tr>
<tr><td width="200"> <b>Others</b></td>
<td width="200">1962-01-07</td>
<td width="200"> Hyperlipidemia()
<tr> <td width="200"></td>
<td width="200"></td>
<td width="200"> Race()
<tr> <td width="200"></td>
<td width="200">1962-02-23</td>
<td width="200"> B 12()
<tr> <td width="200"></td>
<td width="200"></td>
<td width="200"> Sex()
</table><p>
</patient>
<h1 align="center">ATHENA Heart Failure Guideline</h1>
<b>Patient classification:</b> <ul>
<li>ATHENA Heart Failure Guideline: true[because <i> Eligibility criteria </i> evaluate to <b>true</b><i>(Not Stage D HF (refractory end stage HF)Stage D HF (refractory end stage HF))</i>]
</ul>
<b>Scenario choice:</b> Stage C HF
<p>
<b>Goal:</b> LDL< 100 mg/dL(CHD Risk Equivalent)
<p><b>Reached goal?</b> failed(LDL_Cholesterol(114.0/1962-7-13))
<p>
<b>Goal:</b> SBP < 140 and DBP < 80(presence of diabetes mellitus)
<p><b>Reached goal?</b> failed(Treatment_Diastolic_BP(80/null))
<p><b>Messages by Types</b>
<ul>
<li><b>Class II a</b>
<ul>
<li>Maximal exercise testing with or without measurement of respiratory gas exchange is reasonable to facilitate prescription of an appropriate exercise program for patients presenting with HF. (Level of Evidence: C)
</ul>
<li><b>Class I</b>
<ul>
<li>Exercise training is beneficial as an adjunctive approach to improve clinical status in ambulatory patients with current or prior symptoms of HF and reduced LVEF. (Level of Evidence: B)
</ul>
<li><b>Class III</b>
<ul>
<li>Use of nutritional supplements to treat structural heart disease or to prevent the development of symptoms of HF is NOT recommended.
</ul>
</ul>
<p><b>Action Choices</b>
<ul>
<li><b>Stage C HF</b><br>
<ul>
</ul>
<li><b> </b><br>
<ul>
<li><b>General Recommendations <font color=FF0000>preferred</font></b>(strict rule-in condition<i> HF ICD9 code OR( signs and structural abnormality)</i> evaluate to <b> true</b> because <i>Presence of HF</i>)])
Exercise training is beneficial as an adjunctive approach to improve clinical status in ambulatory patients with current or prior symptoms of HF and reduced LVEF. (Level of Evidence: B)
Maximal exercise testing with or without measurement of respiratory gas exchange is reasonable to facilitate prescription of an appropriate exercise program for patients presenting with HF. (Level of Evidence: C)

<li><b>Referrals <font color=FF0000>preferred</font></b>(strict rule-in condition<i> true</i> evaluate to <b> true</i>)])
Class I
<li><b>Stage B HF action <font color=FF0000>preferred</font></b>(strict rule-in condition<i> true</i> evaluate to <b> true</i>)])

Use of nutritional supplements to treat structural heart disease or to prevent the development of symptoms of HF is NOT recommended.
</ul>
</ul>
<b>Considerations for adding drug: </b><ul><li>aldosterone antagonist<ul><li>preference: neutral<li>No comment</ul><li>hydralazine and nitrates<ul><li>preference: neutral<li>No comment</ul><li>Beta blocker for stage C heart failure(Bisoprolol, Sustained release metoprolol succinate, Carvedilol)<ul><li>Already being used<li>preference: ruled out</ul><li>Beta blocker Stage C with MI(Carvedilol)<ul><li>Already being used<li>preference: ruled out</ul></ul><b>Considerations for adding drug: </b><ul><li>ARB<ul><li>preference: neutral<li>No comment</ul><li>Ace_Inhibitor(Enalapril)<ul><li>Already being used<li>preference: ruled out</ul><li>digoxin<ul><li>Already being used<li>preference: ruled out</ul><li>NDHP CCB<ul><li>Contraindications:  Heart_Failure(Cardiomyopathy, Heart_Failure) <li>preference: ruled out</ul><li>Beta blocker stage B post MI(atenolol)<ul><li>Already being used<li>preference: ruled out</ul><li>Beta Blocker Stage B no MI<ul><li>Already being used<li>preference: ruled out</ul></ul></body></html>